PARP1 and central nervous system cancer: In our study, the results showed that flubendazole increased apoptosis among glioma cells via downregulating the expression of Bcl-2, Bcl-xl, and PARP-1, while upregulating the expression of caspase-3, caspase 6 and caspase-9.